Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5267288
Max Phase: Preclinical
Molecular Formula: C24H16ClN5O3
Molecular Weight: 457.88
Associated Items:
ID: ALA5267288
Max Phase: Preclinical
Molecular Formula: C24H16ClN5O3
Molecular Weight: 457.88
Associated Items:
Canonical SMILES: O=C(c1ccncc1)N1N=C(c2ccc([N+](=O)[O-])cc2)CC1c1cc2ccccc2nc1Cl
Standard InChI: InChI=1S/C24H16ClN5O3/c25-23-19(13-17-3-1-2-4-20(17)27-23)22-14-21(15-5-7-18(8-6-15)30(32)33)28-29(22)24(31)16-9-11-26-12-10-16/h1-13,22H,14H2
Standard InChI Key: ASLMAPHQYDSADH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 457.88 | Molecular Weight (Monoisotopic): 457.0942 | AlogP: 5.18 | #Rotatable Bonds: 4 |
Polar Surface Area: 101.59 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 2.97 | CX LogP: 4.46 | CX LogD: 4.46 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.24 | Np Likeness Score: -1.50 |
1. Nehra B, Rulhania S, Jaswal S, Kumar B, Singh G, Monga V.. (2020) Recent advancements in the development of bioactive pyrazoline derivatives., 205 [PMID:32795767] [10.1016/j.ejmech.2020.112666] |
Source(1):